Atlas Trials

A Study of Merestinib (LY2801653) in Healthy Participants

Clinical trial NCT02779738 · COMPLETED

Trial details

NCT number
NCT02779738
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2016-05-01
Primary completion
2016-08-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.